View More View Less
  • 1 National Reference Laboratory for Exanthematous Diseases National Center for Epidemiology, Division of Virology Budapest Hungary
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

In accordance with the 2015 regional goal for measles and rubella elimination of the WHO European Region, only a few imported cases have been documented of both diseases in Hungary for years.This paper presents a case of a Hungarian woman, born in 1975, who received measles vaccination at age of 12 months and later at age of 11 years, according to her certificate of vaccination. In 2009, after arriving home from a vacation in Ireland, she developed acute measles infection with clinical symptoms. It was confirmed by the detection of measles specific IgM, IgA and IgG antibodies, and by detection of viral nucleic acid from throat swab in virus transport medium.Additionally, an outbreak occurred in December of 2011 among a family emigrated from Romania to Hungary. No new measles cases were diagnosed among the contact persons of neither the young Hungarian woman returning from Ireland, nor the family emigrated from Romania. This observation refers to the effectiveness of the Hungarian vaccination program.

  • World Health Organization, Department of Immunization, Vaccines and Biologicals: Manual for the laboratory diagnosis of measles and rubella virus infection http://www.who.int/immunization_monitoring/LabManualFinal.pdf . Accessed 29 January 2012

  • Schneider-Schaulies, J., Schneider-Schaulies, S.: Receptor interactions, tropism, and mechanisms involved in morbillivirus-induced immunomodulation. Adv. Virus Res. 71, 173–205 (2008).

    Schneider-Schaulies S. , 'Receptor interactions, tropism, and mechanisms involved in morbillivirus-induced immunomodulation ' (2008 ) 71 Adv. Virus Res. : 173 -205.

    • Search Google Scholar
  • Griffin, D. E., Oldstone, M. B. A. (eds): Measles — Pathogenesis and Control. Current topics in microbiology and immunology. Vol. 330. Springer-Verlag, Berlin, Heidelberg, 2009.

    '', in Measles — Pathogenesis and Control. Current topics in microbiology and immunology. Vol. 330 , (2009 ) -.

  • Kimura, A., Tosaka, K., Nakao, T.: An immunofluorescent and electron microscopic study of measles skin eruptions. The Tohoku Journal of Experimental Medicine 117, 245–256 (1975).

    Nakao T. , 'An immunofluorescent and electron microscopic study of measles skin eruptions ' (1975 ) 117 The Tohoku Journal of Experimental Medicine : 245 -256.

    • Search Google Scholar
  • Andrews, N., Tischer, A., Siedler, A., Pebody, R. G., Barbara, C., Cotter, S., Duks, A., Gacheva, N., Bohumir, K., Johansen, K., Mossong, J., Ory, F., Prosenc, K., Sláciková, M., Theeten, H., Zarvou, M., Pistol, A., Bartha, K., Cohen, D., Backhouse, J., Griskevicius, A.: Towards elimination: Measles susceptibility in Australia and 17 European country. Bull. World Health Organ. 86, 197–204 (2008).

    Griskevicius A. , 'Towards elimination: Measles susceptibility in Australia and 17 European country ' (2008 ) 86 Bull. World Health Organ. : 197 -204.

    • Search Google Scholar
  • Okonko, I. O., Onoja, B. A., Adedeji, A. O., Ogun, A. A., Udeze, A. O., Ejembi, J., Garba, K. N., Egun O. C., Fowotade, A.: The role of vaccines in elimination and global eradication of measles. A review of literature. African Journal of Pharmacy and Pharmacology 3, 413–425 (2009).

    Fowotade A. , 'The role of vaccines in elimination and global eradication of measles. A review of literature ' (2009 ) 3 African Journal of Pharmacy and Pharmacology : 413 -425.

    • Search Google Scholar
  • Asaria, P., MacMahon, E.: Measles in the United Kingdom: Can we eradicate it by 2010? BMJ 333, 890–895 (2006).

    MacMahon E. , 'Measles in the United Kingdom: Can we eradicate it by 2010? ' (2006 ) 333 BMJ : 890 -895.

    • Search Google Scholar
  • Rigó, Z. N., Szomor, K.: Morbillivírus. In: Takács, M. (ed.): Klinikai és járványügyi virológia. Vox Medica Kiadói Kft., Veszprém, 2011, pp. 407–414.

    Szomor K. , '', in Klinikai és járványügyi virológia , (2011 ) -.

  • WHO: Immunization, Vaccines and Biologicals. http://apps.who.int/immunization_monitoring/en/globalsummary/timeseries/tscoveragebycountry.cfm?C=HUN Accessed 27 January 2012

  • Muscat, M.: Who gets measles in Europe? J. Infect. Dis. 204, 353–365 (2011).

    Muscat M. , 'Who gets measles in Europe? ' (2011 ) 204 J. Infect. Dis. : 353 -365.

  • CDC Morbidity and mortality weekly report. http://www.cdc.gov/mmwr/ Accessed February 1 2012

  • Rigó, Z.: A kiütéses vírusbetegségek differenciáldiagnosztikája. In: Takács, M. (ed.): Klinikai és járványügyi virológia. Vox Medica Kiadói Kft., Veszprém, 2011, pp. 577–592.

    Rigó Z. , '', in Klinikai és járványügyi virológia , (2011 ) -.

  • Schuler, D. (ed.): Gyermekgyógyászati diagnosztika és terápia. Medicina, Budapest, 1988.

    '', in Gyermekgyógyászati diagnosztika és terápia , (1988 ) -.

  • Binder, L., Budai, J., Kátay, A., Nyerges, G. (eds): Fertõzõ betegségek. Medicina, Budapest, 1981.

    '', in Fertõzõ betegségek , (1981 ) -.

  • Rota, J. S., Hickman, C. J., Sowers, S. B., Rota, P. A., Mercader, S., Bellini, W. J.: Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: High risk of infection but low risk of transmission. J. Infect. Dis. Suppl 1, S559–563 (2011).

    Bellini W. J. , 'Two case studies of modified measles in vaccinated physicians exposed to primary measles cases: High risk of infection but low risk of transmission ' (2011 ) Suppl1 J. Infect. Dis. : S559 -563.

    • Search Google Scholar
  • Országos Epidemiológiai Központ: Kanyaró megbetegedések halmozódása Pest megyében. Epinfo, 1, 6–8 (2012).

    'Kanyaró megbetegedések halmozódása Pest megyében ' (2012 ) 1 Epinfo : 6 -8.

 

The author instruction is available in PDF.
Please, download the file from HERE

Senior editors

Editor-in-Chief: Prof. Dóra Szabó (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Managing Editor: Dr. Béla Kocsis (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Co-editor: Dr. Andrea Horváth (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)

Editorial Board

  • Prof. Éva ÁDÁM (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Sebastian AMYES (Department of Medical Microbiology, University of Edinburgh, Edinburgh, UK.)
  • Dr. Katalin BURIÁN (Institute of Clinical Microbiology University of Szeged, Szeged, Hungary; Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary.)
  • Dr. Orsolya DOBAY (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Ildikó Rita DUNAY (Institute of Inflammation and Neurodegeneration, Medical Faculty, Otto-von-Guericke University, Magdeburg, Germany; Center for Behavioral Brain Sciences (CBBS), Magdeburg, Germany)
  • Prof. Levente EMŐDY(Department of Medical Microbiology and Immunology, University of Pécs, Pécs, Hungary.)
  • Prof. Anna ERDEI (Department of Immunology, Eötvös Loránd University, Budapest, Hungary, MTA-ELTE Immunology Research Group, Eötvös Loránd University, Budapest, Hungary.)
  • Prof. Éva Mária FENYŐ (Division of Medical Microbiology, University of Lund, Lund, Sweden)
  • Prof. László FODOR (Department of Microbiology and Infectious Diseases, University of Veterinary Medicine, Budapest, Hungary)
  • Prof. József KÓNYA (Department of Medical Microbiology, University of Debrecen, Debrecen, Hungary)
  • Prof. Yvette MÁNDI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Károly MÁRIALIGETI (Department of Microbiology, Eötvös Loránd University, Budapest, Hungary)
  • Prof. János MINÁROVITS (Department of Oral Biology and Experimental Dental Research, University of Szeged, Szeged, Hungary)
  • Prof. Béla NAGY (Centre for Agricultural Research, Institute for Veterinary Medical Research, Budapest, Hungary.)
  • Prof. István NÁSZ (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Kristóf NÉKÁM (Hospital of the Hospitaller Brothers in Buda, Budapest, Hungary.)
  • Dr. Eszter OSTORHÁZI (Institute of Medical Microbiology, Semmelweis University, Budapest, Hungary)
  • Prof. Rozália PUSZTAI (Department of Medical Microbiology and Immunobiology, University of Szeged, Szeged, Hungary)
  • Prof. Peter L. RÁDY (Department of Dermatology, University of Texas, Houston, Texas, USA)
  • Prof. Éva RAJNAVÖLGYI (Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary)
  • Prof. Ferenc ROZGONYI (Institute of Laboratory Medicine, Semmelweis University, Budapest, Hungary)
  • Prof. Zsuzsanna SCHAFF (2nd Department of Pathology, Semmelweis University, Budapest, Hungary)
  • Prof. Joseph G. SINKOVICS (The Cancer Institute, St. Joseph’s Hospital, Tampa, Florida, USA)
  • Prof. Júlia SZEKERES (Department of Medical Biology, University of Pécs, Pécs, Hungary.)
  • Prof. Mária TAKÁCS (National Reference Laboratory for Viral Zoonoses, National Public Health Center, Budapest, Hungary.)
  • Prof. Edit URBÁN (Department of Medical Microbiology and Immunology University of Pécs, Pécs, Hungary; Institute of Translational Medicine, University of Pécs, Pécs, Hungary.)

 

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: + 36 1 459 1500 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu

 Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded
2020  
Total Cites 662
WoS
Journal
Impact Factor
2,048
Rank by Immunology 145/162(Q4)
Impact Factor Microbiology 118/137 (Q4)
Impact Factor 1,904
without
Journal Self Cites
5 Year 0,671
Impact Factor
Journal  0,38
Citation Indicator  
Rank by Journal  Immunology 146/174 (Q4)
Citation Indicator  Microbiology 120/142 (Q4)
Citable 42
Items
Total 40
Articles
Total 2
Reviews
Scimago 28
H-index
Scimago 0,439
Journal Rank
Scimago Immunology and Microbiology (miscellaneous) Q4
Quartile Score Medicine (miscellaneous) Q3
Scopus 438/167=2,6
Scite Score  
Scopus General Immunology and Microbiology 31/45 (Q3)
Scite Score Rank  
Scopus 0,760
SNIP
Days from  225
sumbission
to acceptance
Days from  118
acceptance
to publication
Acceptance 19%
Rate

2019  
Total Cites
WoS
485
Impact Factor 1,086
Impact Factor
without
Journal Self Cites
0,864
5 Year
Impact Factor
1,233
Immediacy
Index
0,286
Citable
Items
42
Total
Articles
40
Total
Reviews
2
Cited
Half-Life
5,8
Citing
Half-Life
7,7
Eigenfactor
Score
0,00059
Article Influence
Score
0,246
% Articles
in
Citable Items
95,24
Normalized
Eigenfactor
0,07317
Average
IF
Percentile
7,690
Scimago
H-index
27
Scimago
Journal Rank
0,352
Scopus
Scite Score
320/161=2
Scopus
Scite Score Rank
General Immunology and Microbiology 35/45 (Q4)
Scopus
SNIP
0,492
Acceptance
Rate
16%

 

Acta Microbiologica et Immunologica Hungarica
Publication Model Online only Hybrid
Submission Fee none
Article Processing Charge 1100 EUR/article
Regional discounts on country of the funding agency World Bank Lower-middle-income economies: 50%
World Bank Low-income economies: 100%
Further Discounts Editorial Board / Advisory Board members: 50%
Corresponding authors, affiliated to an EISZ member institution subscribing to the journal package of Akadémiai Kiadó: 100%
Subscription fee 2021 Online subsscription: 652 EUR / 812 USD
Subscription fee 2022 Online subsscription: 662 EUR / 832 USD
Print + online subscription: 740 EUR / 930 USD
Subscription Information Online subscribers are entitled access to all back issues published by Akadémiai Kiadó for each title for the duration of the subscription, as well as Online First content for the subscribed content.
Purchase per Title Individual articles are sold on the displayed price.

Acta Microbiologica et Immunologica Hungarica
Language English
Size A4
Year of
Foundation
1954
Publication
Programme
2021 Volume 68
Volumes
per Year
1
Issues
per Year
4
Founder Magyar Tudományos Akadémia
Founder's
Address
H-1051 Budapest, Hungary, Széchenyi István tér 9.
Publisher Akadémiai Kiadó
Publisher's
Address
H-1117 Budapest, Hungary 1516 Budapest, PO Box 245.
Responsible
Publisher
Chief Executive Officer, Akadémiai Kiadó
ISSN 1217-8950 (Print)
ISSN 1588-2640 (Online)

Monthly Content Usage

Abstract Views Full Text Views PDF Downloads
Apr 2021 106 0 0
May 2021 170 0 0
Jun 2021 122 1 0
Jul 2021 184 0 0
Aug 2021 224 0 0
Sep 2021 91 0 0
Oct 2021 0 0 0